Clicky

MannKind Corporation(MNKD) News

Date Title
Oct 9 MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic Pipeline ...
Oct 9 Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
Oct 7 Why MannKind (MNKD) Could Beat Earnings Estimates Again
Sep 30 More Adults With Type 1 Diabetes Achieved A1C Goal (<7%) After Switching From Multiple Daily Insulin Injections or Automated Pumps to Inhaled Insulin (Afrezza®)
Jul 17 Is There An Opportunity With MannKind Corporation's (NASDAQ:MNKD) 49% Undervaluation?
Jul 16 All You Need to Know About MannKind (MNKD) Rating Upgrade to Buy
Jul 16 Is MannKind (MNKD) Outperforming Other Medical Stocks This Year?
Jul 16 MannKind Corporation (MNKD) Hit a 52 Week High, Can the Run Continue?
Jun 22 INHALE-3 Study Reveals Positive Readout in Head-to-Head Comparison of Inhaled Insulin vs. Usual Care in T1D; New Data Presented at American Diabetes Association’s 84th Scientific Sessions
Jun 20 Recent 5.2% pullback isn't enough to hurt long-term MannKind (NASDAQ:MNKD) shareholders, they're still up 327% over 5 years
May 13 MannKind (MNKD) Upgraded to Strong Buy: Here's Why
May 10 MannKind First Quarter 2024 Earnings: Beats Expectations
May 10 MannKind Corp (MNKD) Q1 2024 Earnings Call Transcript Highlights: A Quarter of Robust Growth ...
May 9 MannKind Corporation (NASDAQ:MNKD) Q1 2024 Earnings Call Transcript
May 9 Shareholders May Not Be So Generous With MannKind Corporation's (NASDAQ:MNKD) CEO Compensation And Here's Why
May 9 MannKind (MNKD) Q1 2024 Earnings Call Transcript
May 8 Compared to Estimates, MannKind (MNKD) Q1 Earnings: A Look at Key Metrics
May 8 MannKind (MNKD) Beats Q1 Earnings and Revenue Estimates
May 8 MannKind Corporation Reports 2024 First Quarter Financial Results: Provides Clinical Development Update
May 6 MannKind Receives U.S. FDA Fast Track Designation for Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease